Gf Fund Management Co. Ltd. Kymera Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,413 shares of KYMR stock, worth $91,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,413
Previous 1,538
8.13%
Holding current value
$91,760
Previous $87.1 Million
26.3%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KYMR
# of Institutions
224Shares Held
74MCall Options Held
144KPut Options Held
58.1K-
Baker Bros. Advisors LP New York, NY6.65MShares$432 Million3.07% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.35MShares$412 Million4.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.27MShares$407 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$357 Million16.85% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$337 Million0.05% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.55B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...